-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DckDAoWWZVntd6lXdyhJUh4HoXvbSuX/CnV8JiSTiXcB5AZ1YDJ91gNqSxcpOKZO dqO+U27eyUDXdA3g0vJ6OQ== 0000893220-07-003336.txt : 20071012 0000893220-07-003336.hdr.sgml : 20071012 20071012142453 ACCESSION NUMBER: 0000893220-07-003336 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20071012 DATE AS OF CHANGE: 20071012 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOSE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000877902 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133549286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-141791 FILM NUMBER: 071169323 BUSINESS ADDRESS: STREET 1: 102 ROCK RD CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 2159819000 MAIL ADDRESS: STREET 1: 102 ROCK ROAD CITY: HORSHAM STATE: PA ZIP: 19044 FORMER COMPANY: FORMER CONFORMED NAME: NEOSE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950817 424B3 1 w40760e424b3.htm 424(B)(3) e424b3
 

Filed Pursuant to Rule 424(b)(3)
Registration Statement No. 333-141791
(NEOSE LOGO)
Prospectus Supplement No. 2
Dated October 12, 2007
to the Prospectus dated May 1, 2007
     This prospectus supplement amends the information in the “Selling Stockholders” section of our prospectus dated May 1, 2007 (as amended or supplemented from time to time, the “Prospectus”) relating to the resale of 21,415,447 shares of our common stock and 9,636,950 shares of our common stock issuable upon the exercise of warrants.
     The purpose of this prospectus supplement is to modify the “Selling Stockholders” section of the Prospectus to reflect the sale of warrants to purchase shares of our common stock by HFR SHC Aggressive Master Trust (“HFR SHC AG Fund”), which is listed as a selling stockholder, to OTA LLC (“OTA”), which is hereby added as a selling stockholder.
     This prospectus supplement should be read in conjunction with the Prospectus, and this prospectus supplement is qualified in its entirety by reference to the Prospectus, except to the extent that the information herein modifies or supersedes the information contained in the Prospectus. Except as amended by this prospectus supplement, the “Selling Stockholders” section of the Prospectus is not affected by this prospectus supplement.
     Our common stock is currently traded on the Global Market of the NASDAQ Stock Market LLC under the symbol “NTEC.”
 
     INVESTING IN OUR COMMON STOCK INVOLVES RISKS. YOU SHOULD CAREFULLY CONSIDER THE “RISK FACTORS” INCLUDED IN OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2006 AS WELL AS SUBSEQUENTLY FILED FORMS 10-Q BEFORE YOU DECIDE TO INVEST.
 
     Neither the Securities and Exchange Commission (SEC) nor any other regulatory body has approved or disapproved of these securities or passed upon the adequacy or accuracy of the Prospectus or this prospectus supplement. Any representation to the contrary is a criminal offense.


 

EXPLANATORY NOTE
     The references to the HFR SHC AG Fund in the “Selling Stockholders” table in the section entitled “Selling Stockholders” are hereby amended to reflect the sale by the HFR SHC AG Fund of all of its holdings of warrants to purchase shares of our common stock to OTA.
     The information in the supplement to the “Selling Stockholders” table set forth below is based solely on information provided to us by the HFR SHC AG Fund and OTA as of October 5, 2007.
     This prospectus supplement should be read in conjunction with the Prospectus. The “Selling Stockholders” section of the Prospectus, including the table, is only affected by this prospectus supplement such that the entry for the HFR SHC AG Fund with respect to its warrants to purchase shares of our common stock is replaced with the entry for OTA.
SELLING STOCKHOLDERS
                                         
    Number of Shares of             Number of Shares of     Shares  
    Common Stock     Number of Shares of     Common Stock     Beneficially Owned  
    Beneficially Owned     Common Stock     Underlying Warrants     After Offering  
    Prior to the     Registered for Sale     Registered for Sale              
Name of selling stockholder   Offering     Hereby     Hereby     Number     Percent  
OTA LLC
    44,550             44,550              

GRAPHIC 2 w40760w4076001.gif GRAPHIC begin 644 w40760w4076001.gif M1TE&.#EAJP`V`/<``````(````"``("`````@(``@`"`@,#`P,#GRMAH#!EHS5HI3IKICEKK3ESK4%QJDAVK4QYKTI[M5![KU-^LE6`M%N$ MM5J,M6&)MV6+NFF.NVV2OG26OW.4QG>9P7R[];>ZMG@[-[>[]_E[M[G]^3I[^CL\NGM M].[Q]?+T]_?W^?O[_/O\_/[^_@`````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````/_[\*"@I("`@/\```#_ M`/__````__\`_P#______R'Y!```````+`````"K`#8`AP```(````"``("` M````@(``@`"`@,#`P,#GRMAH#!EHS5HI3IKICEKK3ESK4%Q MJDAVK4QYKTI[M5![KU-^LE6`M%N$M5J,M6&)MV6+NFF.NVV2OG26OW.4QG>9 MP7R[];> MZMG@[-[>[]_E[M[G]^3I[^CL\NGM].[Q]?+T]_?W^?O[_/O\_/[^_@`````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````/_[\*"@I("`@/\```#_`/__````__\`_P#______PC^`+<('$BP MH,&#"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F3*%.J7,FR MI8'MZ='0@77LR8KX(5"*_,R#`VK&6P7B_(L-(0"8H+714WYKO` M`94M-42/'KU`@0^(ERUOX(SP1FP'#WR$N,T[=H,6!XUP^-K[=@,.6!-:81&! M>/'+%:ILL?V\.O1O$2$C] MWWC@A\\I,*E]^WM]W^,-Y`)\_XG%0A8%53%<@6#-UQV#7=WGT',-E,!?;/Y! M*%:`6PRHH64-L%`0"@36Y^"'$6+WW&L&/1A6AAK^-I`-*%[6`'L"$5'CB1]> MAU]U&=!&D(M@P0BAC%L@,4%UA8677`@EUD>!=$3^MP"+$S*Y74%5XJ9;?Q-0 M(.:89)(9@0M;6+$@;UY5$((*+*@0P@65\1;D$DOZYD"89?8I9@:G=;EG!806 M:FBA%$0@A(KY[3=D?U_&MH$3451JZ:68`#!2E6VU\Y@ZT@Z^WS?N0$;U="Y$0_WD0\&T3 MZ+MN?1-0NP40",>FL$,Q1,FK1"36MZ6T%&OLT7\-B"`0Q-DZ&U8%)IQ@PLTX MYXSS"1GP9L1$2N097P@N%.W""BJH$$,/T?:*H0@H1"WUU%0_P6A\UQ8!0'-_E"E"F[#NQ07T8'K M5UM&A+?UQ0O6O"5#J#A%C&/XLPM=,5C!6=/J6-WK"O7F@[W_.=\3!UHXP9/@ M'$:$]V49"]0#99RRB2:L^I90?T_@)]2;XMZ+C_G(0I20M8UV87/(V'IR@=,( MA`I;65)C[(0%@:FO;6\+G'%J()#HA6>`"K/"#D9(PA*2D`,^`UKOP.(!>F'A M"43H@0EW@(+>*.%@I5.7$7;0@Q[Z\(?^/7`@W&P$L"U$X7+/`6$"$2(#D4W$ M@^EI'T-DP)L14BR#'&'3R6ZP/\,MD(`+:UA$`AB;14&$?#::`0[AA\6-:'$@ M6'C/!P\GKR4BZW.QJ8#*&.*$GMTF2"3S30S6:)D)M%$C;QS(W*JC1(@PST89 M2(*X-!"E!L!`(EA`81H)&19##DR0!0E><4`8$2H@,3W%LN,6E,4I"E@M(C7@ M#0\X"98).&IEQCF90*K@QU'2$2P9X($/ADG,8AK3!U9XI&\\-86"B.J+F$&3 MJ'@`Q&KV\`8UO`T$<$*Q&0#AF^`,IS@EI$%0%J1ZOH1F5]HV%B5DLGYM>E,+ MY$2G_0%J"T7^6"<[.;4!^M0H>9C1Y4#TE\X:24!?HV-27YPD$",\`$4-X&#D MT`-0L0A4($]8'V\&B#&+T:AQ_QJ($;;VH7;Y$T45[%*J'81@X7@;?>E_8BK3&H6(6R/]$`>)]T]=V6BE`LEG4-6) M'J(.I#PS-(`9"HNN2'L#8QCKVL1/(``J$$#:= M5@YT(VN=*=+W>I: '][H3"0@`.S\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----